Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2012	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net income (loss)	$ (29,437)	$ (9,040)	$ (56,780)	$ 7,040
Adjustments to reconcile net income (loss) to cash used in operating activities:
Depreciation and amortization	751	2,203	1,605	2,013
Stock-based compensation	171	604	998	1,048
Deferred income taxes	2	2	(98)
Goodwill and intangible assets impairment	21,090		52,434
Other-than-temporary impairment on investment securities	127	23	413	983
Net realized (gains) losses on sales and redemptions of investments	105	(3,265)	(228)	(300)
Other	134	331	397	521
Change in:
Premiums and fees receivable	(824)	(3,915)	817	4,032
Loss and loss adjustment expense reserves	1,012	9,824	(4,774)	(10,775)
Unearned premiums and fees	(308)	4,628	(1,791)	(4,787)
Litigation settlement			(46)	(97)
Other	(149)	2,409	884	(795)
Net cash provided by (used in) operating activities	(7,326)	3,804	(6,169)	(1,117)
Cash flows from investing activities:
Purchases of investments, available-for-sale		(33,174)	(13,324)	(71,939)
Maturities and redemptions of investments, available-for-sale	14,315	41,969	23,260	11,326
Sales of investments, available-for-sale		26,343		12,362
Capital expenditures	(1,533)	(3,603)	(620)	(1,628)
Other	(4)	(1)	(2)	(22)
Net cash provided by (used in) investing activities	12,778	31,534	9,314	(49,901)
Cash flows from financing activities:
Net proceeds from issuance of common stock	23	52	56	67
Purchase of treasury stock	(10,988)
Other	(41)	(37)	(80)	(66)
Net cash provided by (used in) financing activities	(11,006)	15	(24)	1
Net change in cash and cash equivalents	(5,554)	35,353	3,121	(51,017)
Cash and cash equivalents, beginning of period	29,305	23,751	26,184	77,201
Cash and cash equivalents, end of period	$ 23,751	$ 59,104	$ 29,305	$ 26,184